Nestle discloses a method of stabilizing Omega-3 fatty acids.

In this week’s featured patent applications, we cover the latest from Nestle, Abbott, Boston Scientific, Medtronic, Novartis, Roche, Merck, Visa, Intel, Apple, IBM, and Microsoft.

Nestle Seeks to Patent a Method of Stabilizing Omega-3 Fatty Acids

U.S. patent application, US20210030043, discloses a method of stabilizing omega-3 fatty acids such as docosahexaenoic acid (DHA) and/or eicosapentaenoic acid (EPA), and the use of bran or bran extract to prevent or reduce the development of unpleasant odors in oils comprising omega-3 fatty acids.

Abbott Pursues a Patent on Meal Information Collection and Assessment Systems

U.S. patent application, US20210030323,discloses an in-vivo glucose monitoring system linked to an individual’s meal information to provide direct and timely feedback of meal-related glycemic responses using associated software and GUIs. The figures below illustrate various graphical user interface screens of the system.

Boston Scientific Seeks a Patent for a Penile Implant Outer Support Structure

U.S. patent application, US20210030544, describes an implantable device for penile construction having a tissue ingrowth cover that can be disposed between an inflatable member of the penile prosthesis and an interior wall of a neophallus. The figure below illustrates the penile prosthesis device.

Medtronic Wants a Patent for a Medical Device Delivery System with Ribs and Vents

U.S. patent application, US20210030439, discloses a medical device delivery system within a patient’s vasculature that includes a device retaining cup, vent holes for fluid passage, and internal ribs to secure the device within the cup. The figure below illustrates the device retaining cup containing the medical device.

Novartis Pursues a Patent for a Method for Antibodies Targeting MBP6

U.S. patent application, US20210032321, discloses a method for treating anemia through the subcutaneous administration of antibodies or antibody fragments that specifically bind to Bone Morphogenetic Protein-6 (BMP-6).

Roche Eyes a Patent for NKGD2 Antibodies

U.S. patent application, US20210032349, discloses a method for treating disease through the intranasal administration of polynucleotide molecules encoding antibody molecules that target NKGD2, which is a receptor of natural killer (NK) cells.

Merck Files a Patent for Anti-PD-1 Antibodies

U.S. patent application, US20210032342, relates to anti-PD-1 antibodies comprising heavy or light chain CDR regions of humanized 08A affinity matured Fab98, 99, 100, 101, 102, 103, or 104 with or without an S61N glycosylation site correction or G56A deamidation site correction in the CDRH2 region and antigen-binding fragments, which are used in treating cancer or infectious diseases.

Visa Aims to Patent a System for Conducting a Payment Transaction Involving Payment on Delivery

U.S. patent application, US20210035072, discloses a method for conducting a payment transaction involving payment on delivery. The method includes receiving transaction data associated with a payment transaction, determining a financial institution based on the transaction data, communicating the data associated with a request for authorization of the payment transaction, and communicating the data associated with the authorization.

Intel Pursues a Patent for a Method of Automatically Managing Media Content

U.S. patent application, US20210034656, relates to a method of loading new media content on a personal media device. The method includes determining the sufficiency of space for new media content, determining a relative weight associated with old media content. The relative weight corresponds to the possibility of the old media content being rendered on the device in case of insufficiency of storage space. The figure below illustrates the method.

Apple Files a Patent for Utilizing Luminance Changes to Determine User Characteristics

U.S. patent application, US20210035298, discloses a method for identifying a user’s state based on the user’s pupillary response to luminance change events, while viewing content on an electronic device. The illustration below depicts the device displaying the content to the user and obtaining the user’s physiological data.


IBM Wants a Patent Relating to a Method of Detangling Virtual World and Real World Portions of a Set of Articles

U.S. patent application, US20210034784, discloses a machine learning method that includes determining whether an article or portions of an article relates to a real-world event or a virtual world event and perform responsive actions on the determination.

Microsoft Seeks a Patent for Template-Based Calendar Events with Graphic Enrichment

U.S. patent application, US20210034203, describes a method for creating calendar events upon receiving an event request and visual aid selection from a user. The method includes adding a suggested event and an aspect from the visual aid to the user’s calendar and presenting the calendar with a visual background. The figure below illustrates the calendar application user interface where template-based calendar events are created with graphic enrichment.